 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Mar 03, 2023 |
| Title |
Reverse Phase Protein Array (RPPA) - The University of Edinburgh |
| Technology type |
spotted peptide or protein |
| Distribution |
non-commercial |
| Organisms |
Homo sapiens; Mus musculus |
| Manufacturer |
the Host and Tumour Profiling Unit (HTPU, Cancer Research UK, Edinburgh, UK) |
| Manufacture protocol |
https://www.ed.ac.uk/cancer-centre/facilities/htpu-microarray-services/reverse-phase-protein-arrays
|
| |
|
| |
|
| Submission date |
Mar 01, 2023 |
| Last update date |
Mar 03, 2023 |
| Contact name |
Charbel Darido |
| E-mail(s) |
charbel.darido@petermac.org
|
| Organization name |
Peter MacCallum Cancer Center
|
| Department |
Cancer Research
|
| Lab |
Head and Neck Cancer Signaling Lab
|
| Street address |
305 Grattan street
|
| City |
Melbourne |
| State/province |
VIC |
| ZIP/Postal code |
3000 |
| Country |
Australia |
| |
|
| Samples (32)
|
GSM7073847, GSM7073848, GSM7073849, GSM7073850, GSM7073851, GSM7073852
GSM7073853, GSM7073854, GSM7073855, GSM7073856, GSM7073857, GSM7073858, GSM7073859, GSM7073860, GSM7073861, GSM7073862, GSM7073863, GSM7073864, GSM7073865, GSM7073866, GSM7073867, GSM7073868, GSM7073869, GSM7073870, GSM7073871, GSM7073872, GSM7073873, GSM7073874, GSM7073875, GSM7073876, GSM7073877, GSM7073878
|
| Series (2) |
| GSE226356 |
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells [RPPA] |
| GSE226357 |
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells. |
|
| Data table header descriptions |
| ID |
Antibody name |
| SP_LIST |
SwissProt accession list for antibody-targted proteins |
| gene symbols |
Official gene symbols from UniProt/SiwssProt |
| Manufacturer |
Antibody company |
| Product No. |
Product number of the antibody |
| SPOT_ID |
|
| Data table |
| ID |
SP_LIST |
gene symbols |
Manufacturer |
Product No. |
SPOT_ID |
| 4E-BP1 P S65 |
Q13541 |
EIF4EBP1 |
Cell Signaling Technologies |
9451 |
|
| 4E-BP1 P T37,T46 |
Q13541 |
EIF4EBP1 |
Cell Signaling Technologies |
2855 |
|
| Akt |
P31749 |
AKT1 |
Cell Signaling Technologies |
9272 |
|
| Akt P S473 |
P31749 |
AKT1 |
Cell Signaling Technologies |
4060 |
|
| Akt P T308 |
P31749 |
AKT1 |
Cell Signaling Technologies |
2965 |
|
| AMPK alpha |
Q13131 |
PRKAA1 |
Cell Signaling Technologies |
2532 |
|
| AMPK alpha P T172 |
Q13131 |
PRKAA1 |
Cell Signaling Technologies |
2535 |
|
| ATM |
Q13315 |
ATM |
Merck (Calbiochem) |
PC116 |
|
| ATM/ATR Substrate P S/T |
Q13535 |
ATR |
Cell Signaling Technologies |
2851 |
|
| beta-actin |
P60709 |
ACTB |
Cell Signaling Technologies |
4970 |
|
| beta-Catenin |
P35222 |
CTNB1 |
Cell Signaling Technologies |
9562 |
|
| beta-Catenin P S33,S37,T41 |
P35222 |
CTNB1 |
Cell Signaling Technologies |
9561 |
|
| beta-Catenin P T41,S45 |
P35222 |
CTNB1 |
Cell Signaling Technologies |
9565 |
|
| Calpain2 |
P17655 |
CAPN2 |
Cell Signaling Technologies |
2539 |
|
| Calpastatin |
P20810 |
CAST |
Cell Signaling Technologies |
4146 |
|
| Caspase 3 |
P42574 |
CASP3 |
Cell Signaling Technologies |
9662 |
|
| Caspase 3 cleaved |
P42574 |
CASP3 |
Cell Signaling Technologies |
9664 |
|
| CDK1 |
P06493 |
CDK1 |
Cell Signaling Technologies |
9112 |
|
| CDK1 P Y15 |
P06493 |
CDK1 |
Cell Signaling Technologies |
9111 |
|
| c-Jun N-term |
P05412 |
JUN |
Epitomics |
1254-1 |
|
Total number of rows: 103
Table truncated, full table size 5 Kbytes.
| Supplementary data files not provided |
|
|
|
|
 |
Less...
More...